Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,647 | -24,271 | -76,246 | -57,112 | -36,855 |
| Depreciation Amortization | 782 | 391 | 1,301 | 912 | 612 |
| Accounts payable and accrued liabilities | 6,661 | 4,565 | -3,449 | -3,592 | -2,368 |
| Other Working Capital | 15,178 | 9,952 | -4,635 | -1,444 | 619 |
| Other Operating Activity | -5,153 | -3,892 | 5,515 | 5,042 | 3,348 |
| Operating Cash Flow | $-33,179 | $-13,255 | $-77,514 | $-56,194 | $-34,644 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -351 | -357 | -2,712 | -3,047 | -1,891 |
| Investing Cash Flow | $-351 | $-357 | $-2,712 | $-3,047 | $-1,891 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 953 | 64 | 47,804 | 466 | 330 |
| Financing Cash Flow | $953 | $64 | $47,804 | $466 | $330 |
| Beginning Cash Position | 201,015 | 201,015 | 233,437 | 233,437 | 233,437 |
| End Cash Position | 168,438 | 187,467 | 201,015 | 174,662 | 197,232 |
| Net Cash Flow | $-32,577 | $-13,548 | $-32,422 | $-58,775 | $-36,205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,179 | -13,255 | -77,514 | -56,194 | -34,644 |
| Capital Expenditure | -351 | -357 | -2,712 | -3,047 | -1,891 |
| Free Cash Flow | -33,530 | -13,612 | -80,226 | -59,241 | -36,535 |